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Purpose:  Adiponectin is a protein involved in the anti-inflammatory processes in atherosclerotic lesions. Decreased level of adiponectin has 
been observed in patient with coronary artery disease(CAD), diabetes mellitus and metabolic syndrome and the reverse association of plasma 
adiponectin level and atherosclerosis has been shown. There is no data regarding the role of adiponectin in premature CAD. The aim of the study was 
to investigate total and high molecular weight (HMW) adiponectin plasma concentration in young patients with myocardial infarction (MI).
Material and Methods: The studied group consisted of 143 patients (112 men and 31 women), aged under 50 (range 36-49), with MI. The 
control group consisted of 155 healthy people (97 men and 58 women), aged 38-47, without history of CAD. The results derived from studied 
group were compared also with the data derived from 202 patients (130 men and 72 women), suffering from MI, aged over 50 (range 50-92). 
Concentrations of total and HMW adiponectin were measured with Adiponectin (Multimetric) ELISA kit (ALPCO Diagnostics, Salem, NH, USA) 
according to manufacturer’s method.
Results: Total adiponectin mean concentration was 3,81 ug/ml (SD 1,71) in young MI patients, 5,56 (SD 3,12) in MI patients aged over 50 and 
4,65 ug/ml (SD 2,12) in healthy control. HMW adiponectin mean concentration was 1,72 ug/ml (SD 1,11) in young MI patients, 2,88 (SD 2,16) 
in MI patients aged over 50 and 2,31 ug/ml (SD 1,61) in healthy control. Total as well as HMW adiponectin plasma concentration have been 
significantly lower in young MI patients in comparison to MI patients aged over 50 (p<0,0001 and p=0,0002, respectively) and to healthy subjects 
(p<0,0001 and p=0,0003, respectively).
Conclusion: Our study indicates a possible role of decreased adiponectin level as the risk of premature CAD.
